Influence of CYP2C9 and CYP2C19 genetic polymorphisms on pharmacokinetics of gliclazide MR in Chinese subjects

WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT: Gliclazide has been considered metabolized by CYP2C9. Its modified release formulation, gliclazide MR, shows low pharmacokinetic variability in Whites but high variability in Chinese. WHAT THIS STUDY ADDS: The results of this study show that the pharmacokine...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Zhang, Yifan, Si, Dayong, Chen, Xiaoyan, Lin, Nan, Guo, Yingjie, Zhou, Hui, Zhong, Dafang
Natura: Artigo
Lingua:Inglês
Pubblicazione: Blackwell Science Inc 2007
Soggetti:
Pharmacogenetics
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2000619/
https://ncbi.nlm.nih.gov/pubmed/17298483
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2125.2007.02846.x
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi